Flerie AB approved a transaction to transfer its Limited Partnership segment investments to T&M Participation AB, enhancing liquidity and reducing outstanding commitments by approximately SEK 150 million.
Information on the Target
The Extraordinary General Meeting of Flerie AB (publ), registered under the number 559067-6820, convened on December 29, 2025, at 11:00 CET. During this meeting, significant resolutions were made regarding a related-party transaction.
The proposal approved by the Board of Directors involves transferring Flerie’s investments in the Limited Partnership segment to T&M Participation AB, owned by the Company's Chairman, Thomas Eldered. This transaction adheres to the rules governing related-party transactions set forth in Chapter 16a of the Swedish Companies Act (SFS 2005:551), ensuring compliance and transparency.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Sweden
Sweden is renowned for its robust life sciences sector, characterized by a high level of innovation and research activity. The country hosts numerous biotechnology and pharmaceutical companies, which contri
Similar Deals
Flerie Invest AB → Nanologica AB (publ)
2025
ANTCO. Investment Group AB (publ) → Deversify AB
2025
ANTCO. Investment Group AB (publ) → Dynamic Code AB (publ)
2025
T&M Participation AB
invested in
Flerie AB
in 2025
in a Other Corporate deal
Disclosed details
Transaction Size: $11M